A SMART ORO-SOFT PALATE MUCOSAL DRUG DELIVERY: CREDENTIALS AND FUTURE TRENDS

Year 2015, Volume: 19 Issue: 3, 208 - 221, 04.05.2015

Uma Shankar , Satheesh Madhav

Abstract

Over the last few decades pharmaceutical scientists throughout the world are trying to explore transdermal and transmucosal routes as an alternative to injections. The main impediment for the oral delivery of the drugs as potential therapeutic agents is their extensive pre-systemic metabolism, instability in acidic environment associated with inadequate and erratic oral absorption. The parenteral route is the only established route that overcomes all the drawbacks related with the orally inefficient drugs. However the parenteral formulations are expensive, need frequent administration, with less patient compliance and other harmful effects. Since ancient times oral transmucosal drug delivery has received intensive interest for the systemic delivery of drugs proved to have better systemic bioavailability achieved by oromucosal route. Oral mucosal drug delivery provides an alternative method of systemic drug delivery which offers many advantages for both parenterals and oral methods. The oral mucosa is highly vascularised, hence drugs which are absorbed through the oral mucosa directly enter into the systemic circulation, bypassing the enzymes present in the gastrointestinal tract and first-pass metabolism in the liver. The various transmucosal sites available are sublingual and buccal, but also the soft-palatal mucosa was found to be the most convenient and easily accessible novel site for the delivery of therapeutic agents for systemic delivery as retentive dosage forms. It has adequate blood supply, rapid cellular recovery time after exposure to stress, flexible, smooth surface, devoid of mechanical irritation, local discomfort and non-invasive route. Recently soft palate route explore more attention towards the scientist as an alternative to buccal route for administering drugs using mucoadhesive drug delivery dosage forms. This review focuses the more recent advances in novel soft palate route and formulation strategies to design dosage forms to administer drug through this novel soft palate route.

Keywords

Transmucosal delivery, soft palate, permeability and novelistic platform

Faculty of Pharmacy, Dehradoon Institute of Technology, Mussorie diversion Road, Bagawantpur, Makkawala, Dehradoon, Uttarakhand 248009, India. This work was carried out with the support rendered by the respectful Dean, Prof. Dr. KS Lakshmi, SRM College of Pharmacy, SRM University

Abstract

References

• M.J. Rathbone, J. Hadgraft, Absorption of drugs from the human oral cavity, Int. J. Pharm. 74 (1991) 9–24.
• M.E. de Vries, H.E. Bodde, J.C. Verhoef, H.E. Junginger, Developments in buccal drug delivery, Crit. Rev. Ther. Drug Carrier Syst. 8 (1991) 271–303.
• H.E. Bodde, M.E. De Vries, H.E. Junginger, Mucoadhesive polymers for the buccal delivery of peptides, structure–adhesiveness relationships, J. Control. Release 13 (1990) 225–231;
• R.B. Gandhi, J.R. Robinson, Oral cavity as a site for bioadhesive drug delivery, Adv. Drug Deliv. Rev. 13 (1994) 43–74.
• C.A. Squier, P.W. Wertz, Structure and Function of the Oral Mucosa and Implications for Drug Delivery, in: RathboneM.J. (Ed.), Oral Mucosal Drug Delivery, Marcel Dekker, 1996, pp. 1–25.
• JD Smart, Lectin mediated drug delivery in the oral cavity, Adv, drug. Deliv, Rev 56 (2004) 481-489.
• A. Siegel, Permeability of the Oral Mucosa, in: J. Meyer, C.A. Squier, S.J. Gerson (Eds.), The Structure and the Function of Oral Mucosa, Pergamon Press, Oxford, 1984, pp. 95–108.
• C.A. Squier, N.W. Johnson, R.M. Hopps, The Organization of Oral Mucosa, Human Oral Mucosa, Development, Structure and Function, Blackwell Scientific Publications, Oxford, 1976, pp. 7–15.
• S.-Y. Chen, C.A. Squier, The Ultrastructure of the Oral Epithelium, in: J. Meyer, C.A. Squier, S.J. Gerson (Eds.), The Structure and Function of Oral Mucosa, Pergamon Press, Oxford, 1984, pp. 7–30.
• K.W. Gerson, R.R. Harris, The Structure and Function of Oral Mucosa, in: J. Meyer, C.A. Squier, S.J. Gerson (Eds.), The Structure and Function of Oral Mucosa, Pergamon Press, Oxford, 1984, pp. 31–518, 20.
• Allen, A. Bell, S. McQueen, Mucus and Mucosal Protection, in: A. Allen, G. Flemstro, A. Garner, W. Silen, L.A. Turnberg (Eds.), Mechanisms of Mucosal Protection in the Upper Gastrointestinal Tract, Raven Press, New York, 1984, pp. 195–202.
• C.-M. Lehr, From sticky stuff to sweet receptors—achievements, limits and novel approaches to bioadhesion, Eur. J. Drug Metab. Pharmacokinet. 21 (1996) 139–148.
• J. Haas, C.-M. Lehr, Developments in the area of bioadhesive drug delivery systems, Expert Opin. Biol. Ther. 2 (2002) 287–298.
• C.A. Squlcr, N.V. Johnson, Permeability of oral mucosa, Br. Mcd. Bull. 31 (1975) 1969–1975.
• C.A. Squier, R.A. Eady, R.M. Hopps, The permeability of epidermis lacking normal membrane-coating granules: an ultrastructural tracer study of Kyrle–Flegel disease, J. Invest. Dermatol. 70 (1978) 361–364.
• C.A. Squier, B.K. Hall, The permeability of mammalian nonkeratinized oral epithelia to horseradish peroxidise applied in vivo and in vitro, Arch. Oral Biol. 29 (1984) 45–50.
• I.A. Siegel, S.H. Hall, R. Stambaugh, Permeability of the Oral Mucosa, in: C.A. Squier, J. Meyer (Eds.), Current Concepts of the Histology of Oral Mucosa, Carles Thomas, Springfield, IL, 1971, pp. 274–286.
• ZhouaX.H. , Li Wan PoA. , Peptide and protein drugs: II. Non-parenteral routes of delivery, Int. J. Pharm. 75 (1991) 117–130.
• U. Bertram, R. Bodmeier, In situ gelling, bioadhesive nasal inserts for extended drug delivery: in vitro characterization of a new nasal dosage form, Eur. J. Pharm. Sci. 27 (2006) 62–71.
• K.E. Thummel, K.L. Kunze, D.D. Shen, Enzyme-catalyzed processes of first-pass hepatic and intestinal drug extraction, Adv. Drug Deliv. Rev. 27 (1997) 99–127.
• M.T. De Meo, E.A. Mutlu, A. Keshavarzian, M.C. Tobin, Intestinal permeation and gastrointestinal disease, J. Clin. Gastroenterol. 34 (2002) 385–396.
• J. Varshosaz, Insulin delivery systems for controlling diabetes, recent patents on endocrine, Metab. Immune Drug Discov. 1 (2007) 25–40.
• J. Woodley, Bioadhesion: new possibilities for drug administration? Clin. Pharmacokinet. 40 (2001) 77–84.
• J.W. Lee, J.H. Park, J.R. Robinson, Bioadhesive-based dosage forms: the next generation. J. Pharm. Sci. 89 (2000) 850-866.
• J.D. Smart, The basics and underlying mechanisms of mucoadhesion, Adv. Drug Deliv. Rev. 57 (2005) 1556-1568.
• G.P. Andrews, T.P. Laverty, D.S. Jones, Mucoadhesive polymeric platforms for controlled drug delivery, Eur. J. Pharm. Biopharm. 71 (2009) 505-518.
• F. Madsen, K. Eberth, J. Smart, A rheological assessment of the nature of interactions between mucoadhesive polymers and a homogenised mucus gel, Biomaterials 19 (1998) 1083-1092.
• M.I. Ugwoke, R.U. Agu, N. Verbeke, R. Kinget, Nasal mucoadhesive drug delivery: background, applications, trends and future perspectives, Adv. Drug Deliv. Rev. 57 (2005) 1640-1665.
• D. Dodou, P. Breedveld, P. Wieringa, Mucoadhesives in the gastrointestinal tract: revisiting the literature for novel applications, Eur. J. Pharm. Biopharm. 60 (2005) 1-16.
• Ahagon, A.N. Gent, Effect of interfacial bonding on the strength of adhesion, J. Polym. Sci. Polym. Phys. 13 (1975) 1285-1300.
• M.R. Jiménez-Castellanos, H. Zia, C.T. Rhodes, Mucoadhesive drug delivery systems, Drug Dev. Ind. Pharm. 19 (1993) 143-194.
• J.W. Lee, J.H. Park, J.R. Robinson, Bioadhesive-based dosage forms: the next generation, J. Pharm. Sci. 89 (2000) 850-866.
• Shojaei, X. Li, Mechanisms of buccal mucoadhesion of novel copolymers of acrylic acid and polyethylene glycol monomethylether monomethacrylate, J. Control. Rel. 47 (1997) 151-161.
• Ludwig, The use of mucoadhesive polymers in ocular drug delivery, Adv. Drug Deliv. Rev. 57 (2005) 1595-1639.
• N. Fefelova, Z. Nurkeeva, G. Mun, V. Khutoryanskiy, Mucoadhesive interactions of amphiphilic cationic copolymers based on [2- (methacryloyloxy) ethyl] trimethyl ammonium chloride, Int. J. Pharm. 339 (2007) 25-32.
• Portero, D. Teijeiro-Osorio, M. Alonso, C. Remuñán-López, Development of chitosan sponges for buccal administration of insulin, Carbohydr. Polym. 68 (2007) 617-625.
• S. Rossi, F. Ferrari, M. Bonferoni, C. Caramella, Characterization of chitosan hydrochloride-mucin interaction by means of viscosimetric and turbidimetric measurements, Eur. J. Pharm. Sci. 10 (2000) 251-257.
• Bernkop-Schnürch, Chitosan, its derivatives: potential excipients for peroral peptide delivery systems, Int. J. Pharm. 194 (2000) 1-13.
• M.A. Clark, B. Hirst, M. Jepson, Lectin-mediated mucosal delivery of drugs and microparticles, Adv. Drug Deliv. Rev. 43 (2000) 207-223.
• V. Leitner, G. Walker, A. Bernkop-Schnürch, Thiolated polymers: evidence for the formation of disulphide bonds with mucus glycoproteins, Eur. J. Pharm. Biopharm. 56 (2003) 207-214.
• K. Albrecht, M. Greindl, C. Kremser, C. Wolf, P. Debbage, A. Bernkop-Schnürch, Comparative in vivo mucoadhesion studies of thiomer formulations using magnetic resonance imaging and fluorescence detection, J. Control. Rel. 115 (2006) 78-84.
• 42. M. Roldo, M. Hornof, P. Caliceti, A. Bernkop-Schnürch, Mucoadhesive thiolated chitosans as platforms for oral controlled drug delivery: synthesis and in vitro evaluation, Eur. J. Pharm. Biopharm. 57 (2004) 115-121.
• P. He, S. Davis, L. Illum, In vitro evaluation of the mucoadhesive properties of chitosan microspheres, Int. J. Pharm. 166 (1998) 75-88.
• Waugh A., Grant A., Anatomy and physiology in health and illness—the digestive system '10th edition, Churchill Livingstone, 28.
• N.V. Satheesh and M.S. Uma Shankar, A novel oro-soft palatal platform for transmucosal gentamicin delivery, Proceedings of ICSS held at Jadavpur University on 13th February 2008. 21.
• N.V. Satheesh and M.S. Uma Shankar, A. Maurya, A Smart Bioplate from Lallimantia royalena seeds for Trans-soft Palatal Delivery, Proceedings of International Conference on Innovations in Drug Delivery from Biomaterial to Devices Held at Naples, Italy 30th September–3rd October.
• Ahuja, R.K. Khar, J. Ali, Mucoadhesive drug delivery systems, Drug Dev. Ind. Pharm. 19 (1993) 143–194.
• J. Ali, R.K. Khar, A. Ahuja, R. Kalra, Bucoadhesive erodible disk for treatment of orodental infections: design and characterisation, Int. J. Pharm. 238 (2002) 93–103.
• Y.W. Chien, Novel drug delivery system, mucosal drug delivery: potential routes for noninvasive systemic administration, Marcel Dekker, New York, 19928 197.
• K.P.R. Chowdary, L. Srinivas, Mucoadhesive drug delivery system: a review of current status, Indian Drugs 37 (2000) 400–406.
• N.V. Satheesh, M.S. Uma Shankar, A Smart Flexiplate for Oral Transmucosal Soft Palatal Delivery of Amikacin—Proceedings of the International world PSWC, 20078 held in April 22–23, 2007 at Amsterdam, Netherland.
• N.V. Satheesh and M.S. Uma Shankar, A Smart Soft Palatal Platform for Oral Transmucosal Delivery by Using Drug-loaded Mangifera indica, Proceedings of bioplate-Indian Pharmaceutical Congress Held at BHU on 23–25 December 2007.
• D.V. Provenza, SeibellW. , Oral histology: inheritance and development, Philadelphia lie and febiger2nd edition, , 1986, p. 407.
• F. Paulsen, A. Thale, Epithelial-connective tissue boundary in the oral part of the human soft palate, J. Anat. 193 (1998) 457–467.
• Dhaneshwar, L. Rathi, T. Avinash, M. Yogesh, A review on oral mucosal drug delivery system, Int. J. Pharm. Sci. Res. 1 (5) (2010) 50–56.
• T. Disabato-mordarski, I. Kleinberg, Measurement and comparison of the residual saliva on various oral mucosal and dentition surfaces in humans, Arch. Oral Biol. 41 (1996) 655–665.
• L. Eliasson, D. Birkhed, G. Heyden, N. Strömberg, Studies on human minor salivary gland secretions using the Periotron method, Arch. Oral Biol. 41 (1996) 1179–1182.
• J. Kocevar-Nared, J. Kristl, J. Smid-Korbar, Comparative rheological investigation of crude gastric mucin and natural gastric mucus, Biomaterials 18 (1997) 677–681.
• R.D. Specian, M.R. Neutra, Mechanism of rapid mucus secretion in goblet cells stimulated by acetylcholine, J. Cell Biol. 85 (1980) 626–640.
• Squier, C.A., Cox, P., and Wertz, P.W., Lipid content and water permeability of skin and oral mucosa, The J. Invest. Dermat., 96:123-126, 1991.
• Squier, C.A. and Wertz, P.W. Structure and function of the oral mucosa and implications for drug delivery, in eds. M.J. Rathbone, Oral Mucosal Drug Delivery, Marcel Dekker, Inc., New York, New York, 1-26, 1996.
• Soft palate, or velum (human anatomy) Encyclopædia Britannica
• Anatomy of the muscles which construct the soft palate, Author; tamatsu yuichi, mine kazuharu and shimada kazuyuki. Annals of Kagoshima University Dental School.vol.26; no.;page.21-26(2006).
• Biophysical properties of the nature of the soft palate mucus. Received: 4 March 1995 Accepted: 13 April 1995
• Gandhi, R.E. and Robinson, J.R., Bioadhesion in drug delivery, Ind. J. Pharm. Sci., 50:145-152, 1988.
• Harris, D. and Robinson, J.R., Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci., 81:1-10, 1992. Reproduced with permission of the American Pharmaceutical Association
• Wertz, P.W. and Squier, C.A., Cellular and molecular basis of barrier function in oral epithelium, Crit. Rev. Ther. Drug Carr. Sys., 8:237-269, 1991.
• Harris, D. and Robinson, J.R., Drug delivery via the mucous membranes of the oral cavity, J. Pharm. Sci., 81:1-10, 1992. Reproduced with permission of the American Pharmaceutical Association.
• Wertz, P.W. and Squier, C.A., Cellular and molecular basis of barrier function in oral epithelium, Crit. Rev. Ther. Drug Carr. Sys., 8:237-269, 1991.
• Squier, C.A., Cox, P., and Wertz, P.W., Lipid content and water permeability of skin and oral mucosa, The J. Invest. Dermat., 96:123-126, 1991.
• Galey, W.R., Lonsdale, H.K., and Nacht, S., The in vitro permeability of skin and buccal mucosa to selected drugs and tritiated water, J. Invest. Dermat., 67:713-717, 1976.
• Gandhi, R.B. and Robinson, J.R., Oral cavity as a site for bioadhesive drug delivery, Adv. Drug Del. Rev., 13:43-74, 1994.
• N. V. Satheesh Madhav, Emdad Hossain & M. S. Uma Shankar “A Novelistic Trans-Soft Palatal Route for Smart Drug Delivery of Gentamicin by Mucoadhesive Plates” – Proceedings of 17th Singapore Pharmacy Congress, Singapore, July1-4, 2005.
• N. V. Satheesh Madhav, M. S. Uma Shankar & Emdad Hossain “Soft Palate-A Novel Platform For Transmucosal Delivery Of Amickacin”- Proceedings of International Conference on Ethnopharmacology and Alternative Medicine, held at Amla Cancer Institute, Trissur, Kerala, January 20th, 2006.
• N. V. Satheesh Madhav & M. S. Uma Shankar “A smart flexiplate for oral transmucosal soft palatal delivery of Amikacin-Proceedings of the International world PSWC 2007, held in April 22-23, 2007 at Amsterdam, Netherland.
• N. V. Satheesh Madhav, M. S. Uma Shankar & Anil Maurya “A smart bioplate from Lallimantia royalena seeds for trans-soft palatal delivery”- Proceedings of international conference on Innovations in drug delivery from Biomatrerial to devices held at Naples, Italy 30th Sepetmeber-3rd October, 2007.
• M.J. Rathbone, I.G. Tucker, Mechanisms, barriers and pathways of oral mucosal drug permeation, Adv. Drug Deliv. Rev. 12 (1993) 41–60.
• Galey WR, Lonsdale HK, Nacht SY. Permeability studies on buccal mucosae. J Invest Dermatol 1976;67:713-17.
• Marriot, D.R.L. Hughes, in: R. Gurny, H.E. Junginger (Eds.), Mucus Physiology and Pathology Bioadhesion—Possibilities and Future Trends, Wissenschaftliche-Verlagsgesellschaft mbH, Stuttgart, 1990, pp. 29–43.
• E. Puchelle, Rheology, biochemistry and functions of mucus, Biorheology 24 (1987) 411–423.
• P. Verdugo, Goblet cells secretion and mucogenesis, Ann. Rev. Physiol. 52 (1990) 157–176.
• Allen, D.A. Hutton, J.P. Pearson, L.A. Sellars, Mucus glycoprotein, structure, gel formation and gastrointestinal mucus function, mucus and mucosa, Ciba Found. Symp. 109 (1984) 137–156.
• Nagai T, Konishi R. Buccal/gingival drug delivery systems, J Control Rel, 6, 1987, 353- 360.
• Webber W. Mucosal Drug Delivery, Buccal. In: Edith Mathiowitz, editor. Encyclopedia of Controlled Drug Delivery, New York: John Wiley and Sons. Inc, 2, 1999, 553- 563.
• Gupta A, Garg S, Khar R K. Mucoadhesive drug delivery systems: A Review, Ind Drugs, 29(13), 1992, 586-593.
• Goswami S K. Bioadhesive dosage forms: An overview, The Eastern Pharmacist, 15(1), 1994, 85-87.
• Chowdary K P R, Srinivas L. Mucoadhesive drug delivery systems: A review of current Status, Ind Drugs, 37, 2000, 400-406.
• Weatherell J A, Colin R, Rathbone M J. Site specific differences in the salivary concentrations of substances in the oral cavity-Implications for the aetiology of oral disease and local drug delivery, Adv Drug Delivery Rev, 13, 1994, 23- 42.
• Shojaei Amir H, Buccal Mucosa as A Route for Systemic Drug Delivery: A Review, J Pharm Pharmaceut Sci, 1, 1998, 15-30.
• Salamat Miller N, Chittchang M, and Johnston T P. The use of mucoadhesive polymers in buccal drug delivery, Adv. Drug. Deliv. Rev, 57, 2005, 1666-1691.
• Gandhi R B and Robinson J R. Bioadhesion in drug delivery, Indian J.Pharm sci, 50, 1988, 145- 152.
• Sudhakar Y, Kuotsu K and Bandyopadhyay A K. Buccal bioadhesive drug delivery - a promising option for orally less efficient drugs, J. Control. Rel, 114, 2006, 15-40.
• Shojaei AH, Buccal mucosa as a route for systemic drug delivery: a review, J Pharm Pharmaceut Sci., 1(1):15-30, (1998).
• Rathbone M J, Drummond BK, Tucker IG, Oral cavity as a site for systemic drug delivery, Adv. Drug Del. Rev.,13(1-2): 1-22, (1994).
• Nagia, Science and technology of bioadhesive-based targeted oral delivery systems, Pharm. Technol. 32 (11) (2008) 100–121.
• D.E. Chickering, E. Mathiowitz, Definitions, Mechanism, and Theories of Bioadhesion, in: E. Mathiowitz, D.E. Chickering, C.M. Lehr (Eds.), Bioadhesive Drug Delivery System, Marcel Dekker, New York, NY, 1999, pp. 1–10.
• A.A. Mortazavi, H.R. Moghimi, The effect of hydroxyl containing tablet excipients on the adhesive duration of some mucoadhesive polymers, DARU 12 (2004) 11–17.
• M.J. Tobyn, J.R. Johnson, P.W. Dettmar, Factors affecting in vitro gastric mucoadhesion: influence of tablet excipients, surfactants and salts on the observed mucoadhesion of polymers, Eur. J. Pharm. Biopharm. 43 (1997) 65–71.
• N.V. Satheesh Madhav and M. S. Uma Shankar. A Novel biopolymeric smart stabilizer from Cocos Nucifera meat kernel and its pharmaceutical applications. Indian Patent Application filed 2007-09-25/2018/DEL/2007, published; 05-23.(2008).
• Steward, A., Bayley, D.L., and Howes, C. The effect of enhancers on the buccal absorption of hybrid (BDBB) alpha-interferom. Int. J. Pharm 1994; 104:145- 149.
• S. Senel, A.A. Hıncal .Drug permeation enhancement via buccal route: possibilities and limitations. Journal of Controlled Release 2001; 72: 133-144.
• Katrin Moser, Katrin Kriwet, Aarti Naik, Yogeshvar N Kalia, Richard H Guy. Passive skin permeation enhancement and its qualification invitro. European journal of pharmaceutics and Biopharmaceutics 2001; 52:103-112.
• J. Hamman, et al., Enhancement of paracellular drug transport across mucosal epithelia by N-trimethyl chitosan chloride, S.T.P. Pharm. Sci. 10 (2000) 35–38.
• Bernkop-Schnurch, Chitosan and its derivatives: potential excipients for peroral peptide delivery systems, Int. J. Pharm. 194 (2000) 1–13.
• A.H. Shojaei, Buccal mucosa as a route for systemic drug delivery: a review, J. Pharm. Pharm. Sci. 1 (1) (1998) 15–30.
• Bernkop-Schnu¨rch, Mucoadhesive systems in oral drug delivery, Drug Discov. Today Technol. 2 (1) (2005).
• M.J. Rathbone, I.G. Tucker, Mechanisms, barriers and pathways of oral mucosal drug permeation, Adv. Drug Deliv. Rev. 12 (1993) 41–60.
• H. Zhang, J. Zhang, J.B. Streisan, Oral mucosal drug delivery clinical pharmaco-kinetics and therapeutic applications, Clin. Pharmacokinet. 41 (9) (2002) 661–680.
• P. Gilles, F.A. Ghazali, J. Rathbone, Systemic Oral Mucosal Drug Delivery Systems and Delivery Systems, Oral Mucosal Drug Delivery, Marcel Dekker Inc, New York, 1996, pp. 241–285.
• L.L. Christrup, S.N. Rasmussen, M.R. Rassing, Chewing gum as a drug delivery system. IV. Excretion of ascorbic acid in urine after administration of chewing gum and chewing tablets, Farm. Sci. Ed. 16 (1988) 44–67.
• L.N. Jensen, L.L. Christrup, N. Menger, H. Bundgaard, Chewing gum and lozenges as delivery systems for noscapine, Acta Pharm. Nord. 3 (1991) 219–2228 25.
• M.A.H. Russel, M. Raw, M.J. Jarvis, Clinical use of nicotine chewing gum, Brit. Med. J. 280 (1980) 1599–1602.
• Graffner, Some Clinical Results with Respect to Buccal Administration, Minutes European Symposium on Buccal and Nasal Administration as an Alternative to Parenteral Administration, Paris, 10–11 Dec. 1991, 1992, pp. 191–203.
• N.L. Benowitz, P. Jacob, C. Savanapridi, Determinants of nicotine intake while chewing nicotine polacrilex gum, Clin. Pharmacol. Ther. 41 (1987) 467–473.
• L.L. Christrup, J. Bonde, H. Eriksen, S.N. Rasmussen, M.R. Rassing, K. Simonsen, Bioavailability of salicylamide administered in tablets and chewing gum, Farm. Sci. Ed. 16 (1988) 6–14.
• L.L. Christrup, J. Bonde, H. Eriksen, S.N. Rasmussen, M.R. Rassing, Relative bioavailability of (+/−)-verapamil hydrochloride administered in tablets and chewing gum, Acta Pharm. Nord. 2 (1990) 371–376.
• J. Sanjay, J. Anekant, Target-specific drug release to the colon, Exp. Opin. Drug Del. 5 (5) (2008) 483–498.
• B.A. Burnside, A.D. Keith, W. Snipes, Microporous hollow fibers as a peptide delivery system via the buccal cavity, Proc. Int. Symp. Control. Release Bioact. Mater. 16 (1989) 93–94.